Session Abstract – PMWC 2025 Silicon Valley
Speaker Profile
Biography
As Chief Scientific Officer for Clear Labs, Dr. Khaksar leads the vision and strategy for talented teams of dedicated scientists who make life healthier through the application of genomics and intelligent analytics. From a leadership perspective, he prioritize team culture and empower my team members to maximize their talents and push the bounds of what's possible. As a scientist and researcher, Dr. Khaksar have deep insights into the world of health, biotechnology, and next generation sequencing, and Ihe continue to contribute to the world of academia as an adjunct faculty member at Rutgers University. Dr. Khaksar like to leave a legacy by raising the quality of life and health of the world's population. Through his work at Clear Labs, they have made a huge impact on food safety. Dr. Khaksar aim to expand that impact by using my skills to improve clinical and pharmaceutical genomics and their effectiveness in public health.
Talk
Fully-Automated NGS Solution for Infectious Disease Identification and Characterisation
Sequencing Technologies Showcase:
Clear Labs
Clear Labs harnesses the power of next-generation sequencing (NGS) to simplify complex diagnostics for clinical and applied markets. By creating a fully automated platform that brings together DNA sequencing, robotics and cloud-based analytics, Clear Labs democratizes genomics applications to deliver increased clarity.
Speaker Profile
Biography
Eva earned her masters degree at the Technical University of Munich (TUM) in collaboration with the University of Vienna and the Vienna Biocenter Core Facility. Her research focused on optimizing CRISPRCas9 tools for precise knock-ins in mammalian cell lines. With a background in sales, she excels at addressing scientific challenges from a customer perspective, driven by a passion for finding tailored solutions. Eva brings this dedication to her role as Product Manager at Lexogen.
Talk
Lexogen - Leading NGS Services Provider for Cancer Drug Discovery
Lexogen is a leading sequencing services provider offering Innovative Sequencing Technologies for Drug Discovery and preclinical studies with end-to-end solutions for target identification and biomarker discovery from FFPE or blood samples and single cells.
Sequencing Technologies Showcase:
Lexogen
Lexogen is a leading company in RNA sequencing, providing innovative solutions for transcriptome analysis and RNA research. Our products and services are designed to meet the evolving needs of the scientific community, delivering end-to-end solutions for high-quality, reliable results. For more information, visit www.lexogen.com.
Speaker Profile
Biography
Hui Tian is the Co-founder of Axbio Inc., a Silicon Valley-based company specializing in cutting-edge clinical diagnostics platforms. With a strong background in bioengineering and a passion for innovation, Hui has played a pivotal role in the development of Axbios advanced technologies, including fourth-generation nanopore sequencers and multiplex nucleic acid analysis systems. Under his leadership, Axbio has emerged as a leader in genetic testing, infectious disease diagnostics, pharmacogenomics, and oncology. Huis vision and expertise continue to drive advancements in precision medicine and healthcare innovation.
Talk
Axbio's Revolutionary Solutions for Precision Medicine
Discover how Axbios groundbreaking diagnostic platforms, including Bio-CMOS chips, multiplex PCR-microarrays, and nanopore sequencers, are transforming precision medicine. This talk highlights our innovative solutions for infectious disease detection, oncology, and personalized medicine, delivering high accuracy, cost-efficiency, and scalability for clinical and research applications.
Sequencing Technologies Showcase:
Axbio
Axbio Inc., specializes in cutting-edge clinical diagnostics platforms powered by Bio-CMOS chips and e-Chem sensing technologies. With innovations like fourth-generation nanopore sequencers and multiplex PCR-microarrays, Axbio delivers scalable, high-accuracy solutions for precision medicine, addressing needs in infectious disease diagnostics, oncology, genetics, and personalized healthcare.